Keyphrases
Long-acting Injectable
83%
Injectable Drugs
83%
Risperidone
73%
Schizophrenia
66%
Trial Network
62%
Patients with Schizophrenia
57%
Long-acting Preparation
50%
Schizoaffective Disorder
42%
Atypical Antipsychotics
31%
Objective Comparison
31%
New Drugs
24%
Psychotic Relapse
16%
New Preparations
16%
Time Monitoring
15%
Blinded Treatment
15%
Long-acting Injectable Antipsychotics
15%
Fast Startup
15%
Glucose-insulin System
15%
Efficient Data Analysis
15%
Tolerability
15%
Wholesale Price
15%
Manuscript Preparation
15%
Premium Price
15%
Time to Relapse
15%
Oral Antipsychotics
15%
Repeated Assessment
15%
Fluphenazine Decanoate
15%
Paliperidone Palmitate
15%
Olanzapine Pamoate
15%
Market Saturation
15%
Aggressive Marketing
15%
Psychopathology
12%
Network Infrastructure
12%
Successful Implementation
12%
Unit Management
12%
Adverse Events
12%
Service Utilization
12%
Politicians
12%
Primary Outcome Measure
12%
Clinical Setting
12%
Lipids
12%
Clinical Practice
12%
High-quality Data
12%
Prolactin
12%
Data Management
12%
Antipsychotics
11%
Public Health
5%
Pharmacology, Toxicology and Pharmaceutical Science
Microsphere
100%
Risperidone
100%
Schizoaffective Psychosis
58%
Atypical Antipsychotics
41%
Antipsychotic
37%
Typical Antipsychotic
20%
Fluphenazine Decanoate
20%
Tolerability
20%
Paliperidone
20%
Olanzapine
20%
Adverse Event
16%
Prolactin
16%
Nursing and Health Professions
Risperidone
42%
Microsphere
42%
Drug Therapy
33%
Schizoaffective Psychosis
19%
Atypical Antipsychotics
14%
Olanzapine
7%
Paliperidone
7%
Typical Antipsychotic
7%
Fluphenazine Decanoate
7%
Prolactin
7%